EU Novel Food Extension for UV-Treated Mushroom Powder Increases Vitamin D2 Limits to 45mcg

The European Commission has finalized the amendment to Implementing Regulation EU 2017/2470 regarding the use of UV-treated mushroom powder. This update follows a safety assessment by EFSA that confirms higher dosages of Vitamin D2 derived from refined Agaricus bisporus do not pose a risk to the general adult population.

Revised Intake Levels and Pricing Impact

Previously restricted to 10mcg per day, the new limit of 45mcg per day opens the door for high-potency vegan Vitamin D formulations. This shift is expected to drive specific raw material demand as brands move away from synthetic D3 or lichen-based sources.

• UV-treated mushroom powder spot price currently sits at 115 EUR per kg.
• Maximum allowable Vitamin D2 content is now 45mcg per daily dose for adults.
• Exclusion remains for infants and children under 3 years of age.
• Labeling must state UV-treated mushrooms as the specific source of Vitamin D2.

Practical Sourcing Strategy

Formulators should prioritize this mushroom-derived D2 for clean label projects targeting the DACH region. If you are developing a winter immunity SKU for Q4 2026, switch from lichen D3 to this powder. It offers better stability in hard capsules and meets the growing consumer preference for whole-food ingredients over synthetics.

While prices for mushroom powder are roughly 15 percent higher than standard D3, the marketing advantage of a non-synthetic, EU-authorized novel food justifies the margin squeeze for premium brands. Ensure your COA specifically references the UV treatment parameters to comply with the updated regulation.